Ruiz-Torres DA, Naegele S, Podury A, Wirth L, Shalhout SZ, Faden DL. Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis. Oral oncology. 2024;151:106761. doi:10.1016/j.oraloncology.2024.106761.
Revach O-Y, Cicerchia AM, Shorer O, et al. Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.02.12.579184.
Patel AG, Ashenberg O, Collins NB, et al. A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity. bioRxiv : the preprint server for biology. 2024. doi:10.1101/2024.01.07.574538.
Wang M, Ran X, Leung W, et al. ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy. Genes & development. 2023;37(19-20):929-943. doi:10.1101/gad.351084.123.
Zhou Y, Mouw KW. DNA repair deficiency and the immune microenvironment: A pathways perspective. DNA repair. 2024;133:103594. doi:10.1016/j.dnarep.2023.103594.
Liu W, Puri A, Fu D, et al. Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics. Clinical & experimental metastasis. 2023. doi:10.1007/s10585-023-10246-2.
Iorgulescu B, Ruthen N, Ahn R, et al. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Frontiers in immunology. 2023;14:1297932. doi:10.3389/fimmu.2023.1297932.